Wed, Apr 16, 2014, 4:01 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

FAIRFAX FINANCIAL HOLDINGS LTD. Message Board

cactionalpha 185 posts  |  Last Activity: Apr 14, 2014 5:41 PM Member since: Sep 3, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • cactionalpha cactionalpha Apr 14, 2014 5:41 PM Flag

    Keep in mind others have a price target of $18 so the analysts as always are all over the map. Cheers

    Sentiment: Strong Buy

  • Analysts at Leerink Swann started coverage on shares of Kindred Biosciences (NYSE:KIN) in a research report issued to clients and investors on Monday, Analyst Ratings News reports. The firm set an “outperform” rating and a $32.00 price target on the stock. Leerink Swann’s price objective indicates a potential upside of 118.28% from the company’s current price.

    Sentiment: Strong Buy

  • cactionalpha by cactionalpha Apr 14, 2014 5:29 PM Flag

    Thanks to the IPO and the Follow on offering Kindred has enough cash for years.
    Shares sold for $18 and the underwriters bought all of the allotment.

    Within the next 4 months we should hear the results of CereKin. (July or August)

    Expect an acquisition to assist in speeding up the process to market.
    Expect more products to be added to the pipeline

    Expect to hear the results of Sentikin and Atokin within the next 6 months
    Expect applications to be submitted by the end of the year for up to 3 products.

    IF Cerekin is approved it is very likely a larger company will want a piece of it if Kindred decides its in their own best interest. I say this because Richard Chin mentioned that some big companies have already inquired about partnering in regard to selling Cerikin.

    Remember these products can be used in other species which are also in the pipeline (Cats and Horses)

    if you look at the pipeline on their website you can see for yourself how many more products they are working on as we speak. (Biologics)

    Exclusive collaboration with X-Body

    Within 3-5 five years expect Kindred to be bought out.

    Kindred's IPO was only a few months ago and they have achieved so much and the potential is breathtaking
    which is why I think Seth Klarman has taken such a huge position.

    Expect Kindred to be one of the major players in this area within a few years.

    Sentiment: Strong Buy

  • cactionalpha by cactionalpha Apr 10, 2014 5:45 PM Flag

    just made it by the skin of its teeth and the underwriters purchased all of the over allotment shares
    so now Kindred has enough funds to last them years. The correction will not last forever and we can climb back up on positive news. Cheers

    Sentiment: Strong Buy

  • cactionalpha by cactionalpha Apr 10, 2014 4:55 PM Flag

    but this too will pass. Once the Bio correction is over let's try the other direction. Cheers

    Sentiment: Strong Buy

  • Reply to

    Follow on offering completed

    by cactionalpha Apr 8, 2014 5:00 PM
    cactionalpha cactionalpha Apr 8, 2014 5:23 PM Flag

    This is excellent news! Now Kindred has more than enough money as they already had enough through the
    IPO to last them about three years. This means they can add to the pipeline and possibly make an acquisition if need be.
    The underwriters exercised their right to buy all 450,000 shares so that's good news too. Cheers

    Sentiment: Strong Buy

  • cactionalpha by cactionalpha Apr 8, 2014 5:00 PM Flag

    SAN FRANCISCO, California. (April 8, 2014) - Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the closing of its public offering of 3,450,000 shares of its common stock, including 450,000 shares sold pursuant to the exercise in full by the underwriters of their over-allotment option, at a public offering price of $18.00 per share. Kindred Bio estimates net proceeds from the offering to be approximately $58.1 million, after deducting underwriting discounts and commissions and estimated offering expenses.

    Sentiment: Strong Buy

  • On Wednesday at 12:10pm Kindred will give a presentation. Cheers

    Sentiment: Strong Buy

  • Reply to

    So far so good

    by cactionalpha Apr 3, 2014 11:03 AM
    cactionalpha cactionalpha Apr 3, 2014 5:22 PM Flag

    Give it a few trading days. Kindred will have millions of dollars to add more to the pipeline and acquisitions. Cheers

  • cactionalpha by cactionalpha Apr 3, 2014 11:03 AM Flag

    Kindred has sold over 500,000 at a 1.00 more than the 18 bucks announced. Cheers

    Sentiment: Strong Buy

  • cactionalpha by cactionalpha Apr 3, 2014 10:10 AM Flag

    Shares priced at $18 and it looks like 3 million

  • I suspect the follow on offering will be today or tomorrow. Cheers

    Sentiment: Strong Buy

  • Reply to

    Judging from the volume

    by cactionalpha Mar 31, 2014 8:56 PM
    cactionalpha cactionalpha Apr 1, 2014 4:33 PM Flag

    I was wrong about the volume being related to the follow on offering. That is still to come.

  • Reply to

    Judging from the volume

    by cactionalpha Mar 31, 2014 8:56 PM
    cactionalpha cactionalpha Mar 31, 2014 9:06 PM Flag

    Today we joined the Russell Indexes but the volume is at least 2 million shares depending on where you look so I'm assuming this has been timed to coincide with the follow on offering. My assumption could be completely wrong. Cheers

    Sentiment: Strong Buy

  • cactionalpha by cactionalpha Mar 31, 2014 8:56 PM Flag

    we should be finished the follow on offering by tomorrow.

    Sentiment: Strong Buy

  • Reply to

    Public Offering

    by cactionalpha Mar 31, 2014 5:20 PM
    cactionalpha cactionalpha Mar 31, 2014 7:46 PM Flag

    Why would you be in trouble? lol If you want trouble buy HNR.

    Sentiment: Strong Buy

  • Reply to

    Public Offering

    by cactionalpha Mar 31, 2014 5:20 PM
    cactionalpha cactionalpha Mar 31, 2014 7:30 PM Flag

    This follow on offering was first announced on March 19 so this is the first follow on offering.
    Will the share price fall this week who knows but it isn't a certainty by any means.

    Look at the pipeline on the Kindred website and you will see the progress and speed being made.
    The funds from the follow on offering will go to securing relationships like the one announced today
    with X Body and to add to the already impressive pipeline.

    Keep your eye on the business we have a great management team along with world class expertise.

    Sentiment: Strong Buy

  • cactionalpha by cactionalpha Mar 31, 2014 5:20 PM Flag

    4:10 pm Kindred Biosciences announces launch of $50 mln public offering of common stock (KIN) : Co announced the commencement of its public offering of approximately $50 million of shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission. The number of shares to be offered and the public offering price have not yet been determined.

    Sentiment: Strong Buy

  • SAN FRANCISCO, CA and WALTHAM, MA, USA. (March 31, 2014) – Kindred Biosciences, Inc. (NASDAQ: KIN) and X-Body Biosciences (X-Body) jointly announced today an exclusive alliance in which X-Body will discover fully canine, feline, and equine antibodies for companion animal health, and Kindred Bio will develop and commercialize these antibodies. Kindred Bio will provide an upfront payment, research funding, milestones, and royalties, and X-Body will exclusively license these antibodies to Kindred Bio.

    X-Body will use its proprietary DNA-antibody technology and live cell functional selection technology to generate therapeutic antibodies and Kindred Bio will develop these antibodies to address unmet medical needs in companion animal health.

    Sentiment: Strong Buy

  • cactionalpha by cactionalpha Mar 31, 2014 4:31 PM Flag

    Approaching 600 thousand shares as I write at around the closing price. Cheers

    Sentiment: Strong Buy

FFH.TO
470.150.15(+0.03%)3:46 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.